ALVO
NASDAQ · Biotechnology
Alvotech Sa
$4.55
-0.12 (-2.57%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+597.1% upside
Low Target
$22.31
Average Target
$31.72
High Target
$46.94
Current Price
$4.55
Current
$4.55
$4.55
Target
$31.72
$31.72
$22.31
$31.72 avg
$46.94
Scenario Analysis
Bear Case
$22.31
390.3%
Low target
Base Case
$31.72
+597.1%
Avg target
Bull Case
$46.94
+931.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$6.53
-30.3% from high
52-Week Low
$2.94
+54.8% from low
Target vs 52W High
$31.72
+385.8% vs high
Next Earnings Report
Nov 11, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.05
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |